【339 blvd of the allies pittsburgh pa 15222】2019 begins with higher drug prices
The339 blvd of the allies pittsburgh pa 15222 new year is ringing in with higher
drug prices.
Allergan is reportedly setting the pace with increases of nearly 10 percent on more than two dozen products, according to the Wall Street Journal.
While many of the increases are relatively modest, a few are particularly high, including on some generics, the cheaper alternative to branded accounting for nine out of 10 prescriptions filled in the U.S.
Still many price increases exceed
inflation.
More than three dozen drugmakers raised the prices on hundreds of medicines in the U.S. on Tuesday, according to an analysis from Rx Savings Solutions, which sells software to help employers and health plans choose the least-expensive medicines.
The average increase was 6.3 percent, according to the analysis, including increases on different doses for the same drug.
Allergan confirmed the increases cited in the analysis, saying it raised the price of 51 products—27 by about 9.5 percent and another 24 by about 4.9 percent.
The increases covered more than half of its portfolio, from an extended-release version of its Alzheimer’s drug Namenda to dry-eye treatment Restasis.
GlaxoSmithKline confirmed it raised the prices on 36 drugs, although none exceeded 3 percent.
Drug pricing remains a hot topic for Democrats when they take control of the House this week.
Related Articles
Best Buy Celebrates 50 Yrs With Saleathon; Will It Turn 60?
Canadian Solar Is Facing More Challenges Than It Appears
Target Adds Private Bathrooms to Quell Transgender Debate
View comments
(责任编辑:Hotspot)
- ·Delivery Hero takes steps to support struggling restaurants
- ·What Kind Of Shareholder Owns Most Pioneer Distilleries Limited (NSE:PIONDIST) Stock?
- ·What Kind Of Shareholder Appears On The Wanbury Limited’s (NSE:WANBURY) Shareholder Register?
- ·Honda plans to front-load UK production ahead of Brexit
- ·5 Video Conferencing Stocks to Ride on Coronavirus Commotion
- ·Senate GOP Adds 2 Women to Powerful Judiciary Committee, Report Says
- ·Cayan to Debut Industry-Changing Solutions at RetailNOW 2016
- ·Does Cohu, Inc.’s (NASDAQ:COHU) P/E Ratio Signal A Buying Opportunity?
- ·Weekly CEO Buys Highlight
- ·Should You Investigate AVX Corporation (NYSE:AVX) At US$15.07?
- ·Live Oak Acquisition Corp. II Announces Pricing of Upsized $220,000,000 Initial Public Offering
- ·Morgan Stanley Downgrades Hologic On Tough Cynosure Recovery, Surgery Business Risks
- ·BRIEF-Jiangsu Zijin Rural Commercial Bank's Share Trade To Debut On Jan 3 On Shanghai Exchange
- ·Don’t Sell SORIL Infra Resources Limited (NSE:SORILINFRA) Before You Read This
- ·Petrolympic Announces Closing of Private Placement
- ·Capital Report
- ·AG Jennings Names New Leadership Team at Del. DOJ
- ·Second quarter GDP surprises to the upside; first quarter revised down
- ·Iran watchdog passes law on hardening nuclear stance, halting UN inspections
- ·UK lawmakers call for 'strong sanctions' on social media companies that fail to safeguard users